Intriguingly, another recent study found that lower levels of LOX-1 and CD8+ cytotoxic T lymphocyte (CTL) in tumor stroma were related to worse prognosis in CRC patients (195). The gene discussed is OLR1; the disease is colorectal carcinoma.